Viridian Therapeutics
VRDN
VRDN
55 hedge funds and large institutions have $460M invested in Viridian Therapeutics in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 22 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
41% more funds holding
Funds holding: 39 → 55 (+16)
20.85% more ownership
Funds ownership: 86.24% → 107.09% (+21%)
Holders
55
Holding in Top 10
8
Calls
$1.27M
Puts
–
Top Buyers
| 1 | +$36.2M | |
| 2 | +$25.3M | |
| 3 | +$21.3M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$18.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.17M |
Top Sellers
| 1 | -$24.7M | |
| 2 | -$5.93M | |
| 3 | -$2.71M | |
| 4 |
MS
Maven Securities
St Helier,
Jersey
|
-$2.33M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$841K |